Navigation Links
Type II diabetes and the Alzheimer's connection
Date:2/1/2013

Philadelphia, Pa. A research team in Israel has devised a novel approach to identifying the molecular basis for designing a drug that might one day decrease the risk diabetes patients face of developing Alzheimer's disease. The team will present its work at the 57th Annual Meeting of the Biophysical Society (BPS), held Feb. 2-6, 2013, in Philadelphia, Pa.

A recent study suggests that people who suffer from type 2 diabetes face twice the risk of developing Alzheimer's disease later in life compared to those who do not have diabetes. The link these diseases share relates to the formation of two types of peptide deposits that aggregate, or clump together. Peptides are chains of amino acids; longer chains form proteins. One type of peptide, called amyloid beta, is found in Alzheimer plaques in neurons of the brain. The other type, amylin, is found in the pancreas and the brain. Two years ago, researchers found both molecules in the pancreas of diabetic patients, and in both diseases their presence has been linked to the progression of the disease state.

To explore the hypothesis that interactions between the two molecules might play a critical role in the self-assembly of peptides that leads to protein aggregation, Yifat Miller, assistant professor from Ben-Gurion University of the Negev, Beer-Sheva, Israel, characterized the way the two protein molecules interact with each other through an examination of their structure. It was the first analysis of its kind.

"By identifying the specific 'hot regions' of these peptides that strongly interact with each other, our study may provide insight into the link between type 2 diabetes and Alzheimer's disease," Miller says. "We believe that preventing these interactions by developing a drug will decrease the risk that type 2 diabetes patients face of developing Alzheimer's disease later life."

Collaborator Aphrodite Kapurniotu of Technische Universitt Mnchen, Freising-Weihenstephan, Germany, performed the molecular experimental examination of the interactions between these two peptides. Miller's research received funding from the European Union Seventh Framework Programme (FP7/2011).


'/>"/>

Contact: Ellen R. Weiss
eweiss@biophysics.org
240-290-5606
American Institute of Physics
Source:Eurekalert

Related biology news :

1. Joslin scientists find first human iPSC from patients with maturity onset diabetes of the young
2. Researchers identify a new gene with a key role in obesity and diabetes
3. Most-used diabetes drug works in different way than previously thought
4. UCSB researchers perform pioneering research on Type 2 diabetes
5. NTU study finds ways to prevent muscle loss, obesity and diabetes
6. Notre Dame research may have important implications for combating diabetes
7. University of Chicagos Graeme Bell receives international diabetes prize
8. Joslin researchers increase understanding of genetic risk factor for type 1 diabetes
9. Arginine and proline enriched diet may speed wound healing in diabetes
10. Diabetes Management Provider ActiveCare Announces Cost Savings Of Over $4,000 Per Year Per Diabetic Member
11. Purple corn compound may aid in developing future treatments for Type 2 diabetes, kidney disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... YORK , December 22, 2016 ... provider of secure solutions for the e-Government, Public Safety, HealthCare, and ... subsidiary of SuperCom, has been selected to implement and deploy a ... in Northern California , further expanding its presence ... ...
(Date:12/20/2016)... 20, 2016   Valencell , the leading ... STMicroelectronics (NYSE: STM), a global semiconductor leader ... announced today the launch of a new, highly ... that includes ST,s compact SensorTile turnkey ... biometric sensor system. Together, SensorTile and Benchmark deliver ...
(Date:12/16/2016)... --  IdentyTechSolutions America LLC , a leading provider ... a cutting-edge manufacturer of software and hardware security ... integrated solutions that comprise IDT biometric readers and ... IdentyTech,s customers with combined physical identification and anti-tailgating ... theft. "We are proud to use ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... California (PRWEB) , ... January 11, 2017 , ... ... to support fertility specialists with accurate and reliable preimplantation genetic screening (PGS). , ... have achieved excellent results,” says Ovation Fertility Genetics Scientific Director Amy Jones, ...
(Date:1/11/2017)... ... January 11, 2017 , ... ... in clinical settings, it is becoming increasingly clear that the evolution and transmission ... methods, the standard in the study of clinical resistance, has vastly underestimated these ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... Back pain ... Drugs, No Shots and No Surgery for positive back pain relief for WAR members. ... positive results worldwide and could be life changing for millions suffering from chronic back ...
(Date:1/11/2017)... , Jan. 11, 2017 The ... announced that it has partnered with the Bio-Techne ... science research and diagnostics. The partnership was established ... form of receptor for advanced glycation end products ... subject selection for clinical trials in emphysema. Increasing ...
Breaking Biology Technology: